JERSEY CITY, N.J., March 24, 2020 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced the presentation today of a new post-hoc analysis assessing its Phase 3 edaravone study ...

Learn about Amyotrophic Lateral Sclerosis (ALS), its symptoms, risk factors, diagnosis, and current research advancements.

Efgartigimod significantly improves MG-ADL and QMG scores in generalized myasthenia gravis, with early responses linked to shorter disease duration and severe bulbar symptoms. Early responders often ...

—The effort required to manage a patient’s physical manifestations of ALS often overshadows the disease’s psychological burdens. That’s changing. Reviewed by Aaron Miller, MD, Professor of Neurology, ...

Please provide your email address to receive an email when new articles are posted on . The European Medicines Agency has granted orphan drug designation to a small molecule intended to treat spinal ...

BOSTON--(BUSINESS WIRE)--Nido Biosciences (Nido Bio), a clinical stage company developing precision medicines for debilitating neurological diseases, today announced a new publication in Neurology ®, ...